8/19/2014 10:02:02 AM
As if things couldn’t get more competitive in East Cambridge’s office and lab market: Drug giant Amgen Inc. is on the prowl for another 150,000 square feet of space.
The news comes a day after the Boston Business Journal first reported that Bristol-Myers Squibb (NYSE: BMY) was seeking up to 200,000 square feet of new space in East Cambridge and less than two months after a Page 1 story on the stealthy push by local real estate and business development officials to relocate the U.S. headquarters of a major biotechnology firm to the neighborhood. That effort, known locally as Project Tiger, is anticipated to sweep another 400,000 square feet of office and lab space off the East Cambridge market.
comments powered by